Literature DB >> 26563645

Cancer immunotherapy--Converting immune failure to clinical response.

Johanna Olweus1.   

Abstract

Mesh：

Year:  2015        PMID： 26563645      PMCID： PMC5528726          DOI： 10.1016/j.molonc.2015.10.017

Source DB:  PubMed          Journal:  Mol Oncol        ISSN： 1574-7891            Impact factor:   6.603


× No keyword cloud information.
  4 in total

1.  Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy.

Authors:  E D THOMAS; H L LOCHTE; W C LU; J W FERREBEE
Journal:  N Engl J Med       Date:  1957-09-12       Impact factor: 91.245

Review 2.  Therapeutic cancer vaccines: are we there yet?

Authors:  Christopher A Klebanoff; Nicolas Acquavella; Zhiya Yu; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

3.  Cancer immunotherapy--Converting immune failure to clinical response.

Authors:  Johanna Olweus
Journal:  Mol Oncol       Date:  2015-10-30       Impact factor: 6.603

4.  Cancer immunotherapy: moving beyond current vaccines.

Authors:  Steven A Rosenberg; James C Yang; Nicholas P Restifo
Journal:  Nat Med       Date:  2004-09       Impact factor: 53.440
  4 in total
  1 in total

1.  Cancer immunotherapy--Converting immune failure to clinical response.

Authors:  Johanna Olweus
Journal:  Mol Oncol       Date:  2015-10-30       Impact factor: 6.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.